Profile: FDA’s Bakul Patel On The Inevitable Future Of Digital Health

Medtech Insight profiles the man leading the US FDA’s digital health efforts to learn about his journey and vision for the future.

Behtany Hills and Bakul Patel
LIFE SCIENCE ATTORNEY BETHANY HILLS AND THE FDA'S BAKUL PATEL TALK ABOUT THE FUTURE OF DIGITAL HEALTH AT THE 2019 WORLD MEDICAL INNOVATION FORUM IN BOSTON • Source: Ferdous Al-Faruque

Over the past decade, digital health has become a burgeoning sector and ubiquitous term within the medical device industry. As a mountain of new digital heath products are headed to market, everyone is looking to Bakul Patel, associate director for digital health at the Center for Devices and Radiological Health (CDRH), to help develop a new least-burdensome pathway that also ensures patients are kept safe.

In 2017, Patel spoke to a group of stakeholders at the AdvaMed Digital Medtech Conference where he acknowledged that unlike other medical devices, digital health products that are often based...

More from Leadership

Execs On The Move: 5-9 May 2025

 
• By 

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

Guardant Health Launches Germline Hereditary Cancer Test

 

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.

Mirvie Launches Predictive Blood Test For Preeclampsia

 
• By 

Mirvie launched Encompass, a blood test to help identify women over age 35 who are at moderate risk for preeclampsia, and will conduct additional studies to support reimbursements from payers.

Execs On The Move: 28 April - 2 May 2025

 
• By 

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

More from Medtech Insight

TRiCares Tricuspid Valve Replacement System Reduces Regurgitation In First-In-Human Study

 

TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.

Swiss Medtechs Advised To Work On US Tariff Mitigation Strategies

 
• By 

The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.

Guardant Health Launches Germline Hereditary Cancer Test

 

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.